Sean J Yoder
Overview
Explore the profile of Sean J Yoder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
979
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berglund A, Puskas J, Yoder S, Smith A, Marchion D, Qin D, et al.
Cancer Res Commun
. 2025 Feb;
5(3):389-397.
PMID: 39932296
The RSI and 12CK GES are two GESs that predict tumor radiation sensitivity or the presence of tertiary lymphoid structures in tumors, respectively. These GESs were assessed within the CLIA...
2.
Sudalagunta P, Canevarolo R, Meads M, Silva M, Zhao X, Cubitt C, et al.
Cancer Res
. 2024 Oct;
85(2):378-398.
PMID: 39476082
Several therapeutic agents have been approved for treating multiple myeloma, a cancer of bone marrow-resident plasma cells. Predictive biomarkers for drug response could help guide clinical strategies to optimize outcomes....
3.
Alontaga A, Cano P, Ozakinci H, Puskas J, Stewart P, Welsh E, et al.
J Mol Diagn
. 2024 May;
26(8):685-699.
PMID: 38777037
This study describes the validation of a clinical RNA expression panel with evaluation of concordance between gene copy gain by a next-generation sequencing (NGS) assay and high gene expression by...
4.
Gillis N, Dickey B, Colin-Leitzinger C, Tang Y, Putney R, Mesa T, et al.
J Infect Dis
. 2024 Apr;
230(3):680-688.
PMID: 38657098
Background: Cancer-related deaths for people with human immunodeficiency virus (PWH) are increasing due to longer life expectancies and disparately poor cancer-related outcomes. We hypothesize that advanced biological aging contributes to...
5.
Burton C, Bitaraf A, Snyder K, Zhang C, Yoder S, Avram D, et al.
Front Immunol
. 2024 Apr;
15:1353570.
PMID: 38646527
Despite significant advances in the development and refinement of immunotherapies administered to combat cancer over the past decades, a number of barriers continue to limit their efficacy. One significant clinical...
6.
Ho T, Perkins J, Gonzalez R, Hicks J, Martinez R, Duranceau K, et al.
Pharmacogenomics
. 2024 Jan;
25(1):29-40.
PMID: 38189154
Successful treatment with tacrolimus to prevent graft versus host disease (GVHD) and minimize tacrolimus-related toxicities among allogeneic hematopoietic cell transplantation (alloHCT) recipients is contingent upon quickly achieving and maintaining concentrations...
7.
Welch D, Fridley B, Cen L, Teer J, Yoder S, Pettersson F, et al.
Sci Rep
. 2023 Nov;
13(1):20125.
PMID: 37978271
Osteosarcoma is the most common bone sarcoma in children and young adults. While universally delivered, chemotherapy only benefits roughly half of patients with localized disease. Increasingly, intratumoral heterogeneity is recognized...
8.
Hall M, Teer J, Yu X, Branthoover H, Snedal S, Rodriguez-Valentin M, et al.
J Immunother Cancer
. 2023 Oct;
11(10).
PMID: 37802604
Background: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) is a promising immunotherapeutic approach for patients with advanced solid tumors. While numerous advances have been made, the contribution of neoantigen-specific...
9.
Sasamoto N, Stewart P, Wang T, Thompson Z, Yoder S, Hecht J, et al.
Cancer Med
. 2023 Aug;
12(17):18405-18417.
PMID: 37525619
Background: Aspirin use has been associated with reduced ovarian cancer risk, yet the underlying biological mechanisms are not fully understood. To gain mechanistic insights, we assessed the association between prediagnosis...
10.
El-Kenawi A, Berglund A, Estrella V, Zhang Y, Liu M, Putney R, et al.
Cancer Res
. 2022 Dec;
83(5):720-734.
PMID: 36480167
Significance: Methionine enables cancer cells to persist by evading pyroptotic osmotic lysis, which leads to genome-wide hypermethylation that allows persisters to gain proliferative advantages.